BIOLIFE SOLUTIONS INC

BOTHELL, WA · CIK 0000834365 · Biotech · Public

Biopreservation media and systems for cryopreserving cells and tissues used in cell and gene therapies

biolifesolutions.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$10M
1 Form D · Oct 2023
36 months since last filing
Contracts
—
No federal contracts on record
Patents
26
12 granted · 14 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$10,374,976
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1432Jericho Sciences, LLC——
1433Starwise Therapeutics LLC——
1434ALLYX THERAPEUTICS INC—$40M
1435BIOLIFE SOLUTIONS INC—$10M
1436TransChromix LLC——
1437ENTERX BIOSCIENCES, INC.——
1438UCB S.A.—$788K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 13 related persons
  • Sarah AebersoldExecutive Officer
  • Todd BerardExecutive Officer
  • Roderick De GreefDirector · Executive Officer
  • Amy DuRossDirector
  • Rachel EllingsonDirector
  • Karen FosterExecutive Officer
  • Joydeep GoswamiDirector
  • Aby MathewExecutive Officer
  • Tim MooreDirector
  • Geraint PhillipsExecutive Officer
  • Michael RiceDirector · Executive Officer
  • Joseph SchickDirector
  • Troy WichtermanExecutive Officer

Patents

USPTO · 12 granted of 26

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.